Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2847 (LINC02847) is an autonomously transcribed non-coding RNA gene found in the human genome, classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are longer than 200 nucleotides and do not overlap protein-coding genes, typically acting in gene regulation, chromatin remodeling, and RNA/protein scaffolding[3][8]. While many lincRNAs are implicated in diverse regulatory pathways and diseases—including cancer, immune responses, and cell differentiation—there is currently no specific information linking LINC02847 to drug interactions, therapeutic targeting, or biomarker applications. It shares the general molecular and functional characteristics of lincRNAs, such as transcriptional regulation and possibly involvement in chromatin modification, but its individual biological and disease roles remain to be elucidated[1][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2847 (LINC02847).